finder.com.au

How to buy Control Bionics shares

Control Bionics is now trading publicly on the ASX, here’s what you need to know if you’re looking to buy shares.

Updated

Fact checked

What we know so far

Offer price: $0.60
Proposed code: CBL
Expected raise: $15 million
Expected listing: 7 December 2020

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Control Bionics shares are now publicly available to purchase on the Australian Securities Exchange (ASX). Here's how you can buy in.

How to invest in the Control Bionics IPO

Control Bionics has listed on the ASX, so you can now buy shares over the stock market. To do that, you'll need to be signed up to a broker. Your cheapest option is to sign up to an online broker. Check out the steps below:

How to buy shares when Control Bionics lists

  1. Compare share trading platforms. To buy shares in an Australian-listed company, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Control Bionics. Find the share by name or ticker symbol: CBL. You can also search for any other shares traded publicly on exchanges available within your chosen platform.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Control Bionics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At price of at you're buying the shares, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Control Bionics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What we know about the Control Bionics IPO

Control Bionics lodged its prospectus with the Australian Securities and Investments Commission (ASIC) to list on the ASX under the ticker symbol CBL.

Morgans Corporate Limited were appointed as lead managers with an expected raise of $15 million at $0.60 per share. You can check out some of the key dates and figures in the table below:


Control Bionics IPO key numbers
Offer price $0.60
Dividend yield 0%
Total number of shares available under the offer 25 million
Proposed ASX code ASX: CBL
Target market cap $50 million
Retail offer opens 11 November 2020
Retail offer closes 25 November 2020
Expected listing on ASX 7 December 2020
Expected dispatch of holding statements 2 December 2020
Source: Control Bionics prospectus

According to latest information available, retail investors (regular investors) have between 11 November 2020 and 25 November 2020 to participate in the Control Bionics IPO. After the retail offer close date, you'll need to wait until the stock is publicly available on the ASX to buy shares.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data indicated here is updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
IG Share Trading
Finder Award
IG Share Trading
AUD 8 or 0.1%
AUD 50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares, Forex, CFDs, Margin trading
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
Go to site
More Info
Bell Direct Share Trading
Finder Award
Bell Direct Share Trading
AUD 15
No
ASX shares, Options trading, mFunds, ETFs, Warrants
Invest in Australian shares, options and managed funds from the one account with no inactivity fee.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
Go to site
More Info
Superhero share trading
Superhero share trading
AUD 5
No
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Go to site
More Info
CMC Markets Stockbroking
Finder Award
CMC Markets Stockbroking
AUD 11 or 0.1%
No
ASX shares, Global shares, Forex, CFDs, Options trading, mFunds, ETFs, Warrants
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
Go to site
More Info
SelfWealth Share Trading (Basic account)
SelfWealth Share Trading (Basic account)
AUD 9.5
No
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
Go to site
More Info
ANZ Share Investing
ANZ Share Investing
AUD 19.95
No
ASX shares, Global shares, Options trading, mFunds, ETFs, Warrants
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
More Info
Westpac Online Investing Account
Westpac Online Investing Account
AUD 19.95 or 0.11%
USD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, ETFs
More Info
loading

Compare up to 4 providers

Balance sheet

In FY20 , the Company generated $3,099,000 of revenue. Estimated net profit (NPAT) in FY20 was -1,503,000, and -$2,500,000 in the prior year.

Company history

Control Bionics launched in 2006 by Peter Ford and is headquartered in Surry Hills, NSW.

How do I buy shares?

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site